cro.directory
← Compare landing

Cyagen Biosciences vs VIRSCIO

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/apac-cyagen/virscio

CategoryCyagen BiosciencesVIRSCIO
Listed sitecrocro
SummaryCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.Virscio runs African green monkey studies for efficacy, safety, PK/PD and delivery alongside digital histopathology and molecular biology. Its GLP-operated, AAALAC-accredited primate program supports IND-enabling work in CNS, ophthalmology, and gene therapy.
Services
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • Preclinical In Vitro Studies
  • In Vivo Efficacy Models
  • Translational Research
  • Discovery Research
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Specialized & Large-Animal Models
  • Pathology & Histology Services
  • Translational Research
  • Regulatory Affairs
Modalities
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Gene Therapy
  • Cell Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Rare Disease
  • Ophthalmology
  • Neurology
  • Ophthalmology
  • Cardiovascular
  • Metabolic
Locations
  • Headquarters, Santa Clara, California, United States
  • New Haven, New Haven, CT, United States
Certifications
  • AAALAC · Identifier: AAALAC-accredited facilities
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.